Subcutaneous emphysema is a potential complication after thoracic surgical procedures. Most cases of emphysema are self-limiting, requiring no specific management, but some cases can be massive, rapidly inflating, severely disturbing the airway, and becoming life-threatening. The main risk of subcutaneous emphysema is rapid and massive accumulation of air in the deep fascial planes at the level of the thoracic inlet [1] . Therefore, a massive accumulated air can compress the trachea and the great vessels, which can severely compromise the airway, venous return, and blood flow to the head and neck. A few treatments for subcutaneous emphysema, such as needle aspiration, small-bore-catheter insertion, chest tube insertion, and multiple skin incision-like 'blow-holes,' have been reported [2] . Recently, negative pressure wound therapy, as known as vacuum-assisted closure (VAC), has been emerging as an effective treatment modality for wounds ranging from simple wounds to complex septic wounds. This therapeutic method, firstly introduced by Argenta and Morykwasin in 1997, is based on the effects of a negative pressure of 75 to 150 mmHg on wound healing. Many different terms, such as vacuum therapy, topical negative pressure wound therapy, and VAC, have been used to describe it since then. The vacuum device has demonstrated great utility in decreasing edema via a negative pressure gradient that pulls fluid out of wounds. Therefore, we applied this technique for subcutaneous emphysema with the placement of a VAC dressing to decrease the subcutaneous air.
CLINICAL SUMMARY AND TECHNIQUE
A total of 4 patients who all had been suffering from secondary pneumothorax with massive subcutaneous emphysema that was intractable despite chest tube drainage underwent VAC therapy at the department of thoracic and cardiovascular Duration of subcutaneous emphysema before VAC therapy. surgery of Eulji University Hospital. All were male. The median age of the patients was 73.3 years (range, 63 to 87 years). Table 1 shows that all of the patients had chronic obstructive pulmonary disease with emphysematous lungs. The patients were first treated by closed-tube thoracostomy, but subsequently abrupt massive subcutaneous emphysema occurred. A 2-cm 'blow-hole' incision was made below the right or left infraclavicular region through the skin and the prepectoral fascia was exposed sufficiently at the bedside under local anesthesia. Sterile polyurethane foam was trimmed to shape and placed into the blow-hole incision (Fig. 1A, B ).
An adhesive drape was used to cover the foam and an additional 3 to 5 cm of surrounding intact skin. An opening hole was created in the adhesive drape and a non-collapsible tube connector was placed directly over the hole in the drape ( Co., Ltd., South Korea) and negative pressure was applied.
As a result, the VAC device absorbed subcutaneous air via the blow-hole incision. The topical VAC dressing was set at a continuous suction of 150 mmHg (Fig. 1E, F) . The VAC dressing changes were performed at the bedside using a sterile technique every other day. The mean time to VAC therapy was 1.5 post-closed thoracostomy days (range, 0 to 3 days) and the mean duration of VAC therapy was 3.0 days (range, 2 to 4 days). After application of the VAC therapy,
we performed a chest X-ray scan and physical examination daily to measure the subcutaneous emphysema. All of the patients experienced a dramatic reduction in trapped air after 24 hours of VAC therapy (Fig. 2) . Two patients were able to have the VAC device removed within 48 hours, and all of the VAC machines were withdrawn within 4 days. The VAC device was removed when near-complete resolution of sub- VAC therapy did not replace tube thoracostomy in these 4 cases; it is an adjunct to therapy for subcutaneous emphysema once a chest tube has been placed. Wound site pain is a common complication after VAC therapy. It is controlled with pressure adjustment between 75 mmHg and 150 mmHg.
Other considerations, such as increased wound care needs, the potential for development of wound infections, and equipment costs must be carefully evaluated prior to initiation of VAC therapy for subcutaneous emphysema.
CONCLUSION
In various methods of massive subcutaneous emphysema treatment, VAC therapy is easily usable and rapidly effective for evacuating subcutaneous trapped air in large air leak patients.
